Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc.
This Memorandum and Order addresses the determination of reasonable attorneys' fees and disbursements following a finding that defendants willfully infringed plaintiffs' patent for famotidine in a previous trial. Judge Owen reviews objections from the defendants regarding various billing practices, including rates, staffing, hotel expenses, and in-house counsel fees. The court ultimately reduces the requested attorneys' fees by 30% to $1,635,440 and awards adjusted disbursements of $400,000, deeming these amounts a fair resolution of the defendants' contentions.